When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Fetal alcohol spectrum disorder - Wikipedia

   en.wikipedia.org/wiki/Fetal_alcohol_spectrum...

   FAS is believed to occur in between 0.2 and 9 per 1,000 live births in the United States. [117] Using medical and other records, CDC studies have identified 0.2 to 1.5 infants with FAS for every 1,000 live births in certain areas of the United States. [118]

3. Alpha-glucosidase inhibitor - Wikipedia

   en.wikipedia.org/wiki/Alpha-glucosidase_inhibitor

   Alpha-glucosidase inhibitors (AGIs) are oral anti-diabetic drugs used for diabetes mellitus type 2 that work by preventing the digestion of carbohydrates (such as starch and table sugar). They are found in raw plants/herbs such as cinnamon and bacteria (containing the inhibitor acarbose ).

4. Type 1 diabetes - Wikipedia

   en.wikipedia.org/wiki/Type_1_diabetes

   The mainstay of type 1 diabetes treatment is the regular injection of insulin to manage hyperglycemia. [48] Injections of insulin via subcutaneous injection using either a syringe or an insulin pump are necessary multiple times per day, adjusting dosages to account for food intake, blood glucose levels, and physical activity. [48]

5. Autoimmune polyendocrine syndrome type 2 - Wikipedia

   en.wikipedia.org/wiki/Autoimmune_polyendocrine...

   Autoimmune polyendocrine syndrome type 2, a form of autoimmune polyendocrine syndrome also known as APS-II, or PAS II, is the most common form of the polyglandular failure syndromes. [2] PAS II is defined as the association between autoimmune Addison's disease and either autoimmune thyroid disease , type 1 diabetes , or both. [ 5 ]

6. Diabetes medication - Wikipedia

   en.wikipedia.org/wiki/Diabetes_medication

   Type 2 diabetes is the most common type of diabetes. Treatments include agents that (1) increase the amount of insulin secreted by the pancreas, (2) increase the sensitivity of target organs to insulin, (3) decrease the rate at which glucose is absorbed from the gastrointestinal tract, and (4) increase the loss of glucose through urination.

7. Teplizumab - Wikipedia

   en.wikipedia.org/wiki/Teplizumab

   Teplizumab, sold under the brand name Tzield, is a humanized anti-CD3 monoclonal antibody that is the first approved treatment indicated to delay the onset of stage 3 type 1 diabetes in people with stage 2 type 1 diabetes. [3] [4] [5] The Fc region of this antibody has been engineered to have Fc receptor non-binding (FNB) properties. [6]